Developing an intervention to improve follow-up of abnormal fecal immunochemical test results in a safety-net population using a mixed methods approach
使用混合方法制定干预措施,以改善安全网人群中异常粪便免疫化学检测结果的随访
基本信息
- 批准号:9806781
- 负责人:
- 金额:$ 28.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-01 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdherenceAdoptedAdvocateApplications GrantsAreaBehavior TherapyCancer ControlCancer EtiologyCaringCessation of lifeCharacteristicsClinicClinicalClinical ResearchColonoscopyColorectal CancerCommunicationCommunitiesComplementDataDevelopmentDiagnosticDocumentationElectronic Health RecordEnvironmentEvaluationEvidence based interventionFailureFecesFederally Qualified Health CenterFocus GroupsFred Hutchinson Cancer Research CenterFrequenciesFundingGastroenterologistGastroenterologyGoalsHealthHealth PolicyHealth ServicesHealth systemHealthcareIndividualInterventionInterviewK-Series Research Career ProgramsLungMalignant NeoplasmsMedicalMedical centerMentorsMentorshipMethodsNurse AdministratorOutcomes ResearchPathway interactionsPatient PreferencesPatientsPhysician ExecutivesPopulationProspective StudiesProviderQualitative MethodsQualitative ResearchReportingResearchResearch MethodologyResearch PersonnelResearch TrainingResourcesScientistScreening ResultStatistical ModelsStructureSystemTest ResultTestingTrainingTraining ProgramsTreatment EfficacyUniversitiesWashingtonWorkbasebehavior changecancer preventioncareerclinical carecolorectal cancer preventioncolorectal cancer screeningcontextual factorsdesigneffective interventionexperiencefollow-upimplementation scienceimprovedinnovationmedical specialtiesmedically underservedmedically underserved populationmethod developmentmortalitymultilevel analysisnovelperformance testsrandomized trialresearch and developmentsafety netscreeningskillssocial cognitive theorysuccesstherapy development
项目摘要
Project Summary
Rachel Issaka, MD, MAS’ long-term career goal is to become an independent researcher and leader in
developing, implementing, and evaluating interventions to reduce colorectal cancer (CRC) mortality in medically
underserved populations. She has identified improving follow-up of abnormal fecal immunochemical test (FIT)
results as a critical issue to address to achieve this goal. This proposal describes a 5-year comprehensive
program of training and mentored research for an academic career in health outcomes research. The research
agenda is in line with one of NCI’s five scientific goals: to improve cancer prevention and control. In this goal,
advancing health care equity in medically underserved populations is an area of special focus. While Dr. Issaka
has a strong background in clinical gastroenterology and safety-net systems-level research, this K08 will provide
key training in advanced multilevel statistical modeling, qualitative research methods, mixed methods research,
and intervention development. FIT is promoted over colonoscopy for CRC screening in federally qualified health
centers (FQHCs) and safety-net health systems due to patient preference and limited colonoscopy resources.
For FIT-based screening to effectively reduce CRC-mortality, abnormal results must be followed by a diagnostic
colonoscopy. However, FQHCs and safety-net health systems do not consistently track follow-up of abnormal
FIT results and failure to complete a diagnostic colonoscopy increases CRC-mortality by up to 3-fold. Research
suggests approximately 50% of safety-net patients with an abnormal FIT do not complete a diagnostic
colonoscopy within 1 year of their result. This highlights the importance of identifying and describing the barriers
to diagnostic colonoscopy completion after abnormal FIT results in order to develop effective interventions. The
study’s specific aims are: (1) using mixed methods, identify the potentially modifiable patient, provider, and clinic-
level barriers to diagnostic colonoscopy in patients with abnormal FIT results in a large safety-net health system;
and (2) based upon intervention targets identified in Aim 1, develop a pilot intervention to improve diagnostic
colonoscopy completion in a safety-net population with abnormal FIT results. Dr. Issaka’s mentorship team
including world-renowned gastroenterologists, health services researchers, qualitative and mixed methods
experts and implementation scientists will provide experiential guidance to complement her didactic training.
These factors in addition to the supportive research environments at the Fred Hutchinson Cancer Research
Center and the University of Washington, will enable her to achieve the proposed project aims. Upon completion
of the proposed research and training, Dr. Issaka will submit a competitive R-level grant application to test the
pilot intervention in a randomized trial and will possess the skills and experience to make sustained and impactful
contributions to reduce CRC-mortality through evidence-based interventions that improve follow-up of abnormal
FIT results.
项目摘要
Rachel Isabel,医学博士,MAS的长期职业目标是成为一名独立的研究人员和领导者,
制定,实施和评估干预措施,以降低结肠直肠癌(CRC)的死亡率,
服务不足的人群。她已经确定改善异常粪便免疫化学试验(FIT)的随访
成果作为实现这一目标的一个关键问题。该提案描述了一项为期5年的全面
培训和指导研究的健康结果研究的学术生涯计划。研究
该议程符合NCI的五个科学目标之一:改善癌症预防和控制。在这个目标中,
促进医疗服务不足人口的保健公平是一个特别关注的领域。当伊斯雷尔博士
在临床胃肠病学和安全网系统级研究方面有很强的背景,K 08将提供
高级多层次统计建模,定性研究方法,混合方法研究,
干预发展。FIT比结肠镜检查更适合在联邦合格的健康检查中进行CRC筛查
由于患者的偏好和有限的结肠镜资源,结肠镜检查中心(CNOHC)和安全网卫生系统。
对于基于FIT的筛查,以有效降低CRC死亡率,异常结果必须遵循诊断
结肠镜检查然而,联合国卫生组织和安全网卫生系统并不一贯地跟踪异常
FIT结果和未能完成诊断性结肠镜检查会使CRC死亡率增加3倍。研究
表明大约50%的FIT异常的安全网患者没有完成诊断
结肠镜检查结果1年内。这突出了识别和描述障碍的重要性
在FIT结果异常后完成诊断性结肠镜检查,以便制定有效的干预措施。的
研究的具体目标是:(1)使用混合方法,确定潜在的可改变的患者,提供者和诊所-
FIT异常患者的诊断性结肠镜检查水平障碍导致大型安全网卫生系统;
以及(2)根据目标1中确定的干预目标,制定试点干预措施,以改善诊断
在FIT结果异常的安全网人群中完成结肠镜检查。Isabel博士的导师团队
包括世界知名的胃肠病学家、卫生服务研究人员、定性和混合方法
专家和执行科学家将提供经验指导,以补充她的教学培训。
除了弗雷德哈钦森癌症研究中心的支持性研究环境外,
中心和华盛顿大学的合作,将使她能够实现拟议的项目目标。完成后
在拟议的研究和培训中,Islam博士将提交一份具有竞争力的R级资助申请,以测试
在随机试验中进行试点干预,并将拥有持续和有效的技能和经验,
通过循证干预措施,改善异常患者的随访,
FIT结果。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rachel B. Issaka其他文献
Mailed FIT to Improve Colorectal Cancer Screening in an Integrated Safety-Net System
邮寄 FIT 以改善综合安全网系统中的结直肠癌筛查
- DOI:
- 发表时间:
2017 - 期刊:
- 影响因子:0
- 作者:
Carly Rachocki;Victoria Laleau;D. Garcia;Rachel B. Issaka;Ellen H. Chen;L. Golden;B. Grimes;E. Vittinghoff;J. Shapiro;U. Ladabaum;M. Somsouk - 通讯作者:
M. Somsouk
COLONOSCOPY QUALITY METRICS ACCORDING TO INDICATION: AVERATE RISK SCREENING VS. ABNORMAL FOBT VS. ABNORMAL FIT-DNA. RESULTS FROM A NATIONAL ENDOSCOPY REGISTRY
根据适应证的结肠镜检查质量指标:平均风险筛查与粪便潜血试验异常与粪便免疫化学检测-基因检测异常。来自一个国家内镜登记处的结果
- DOI:
10.1016/j.gie.2025.03.364 - 发表时间:
2025-05-01 - 期刊:
- 影响因子:7.500
- 作者:
Jason A. Dominitz;Jennifer L. Holub;Rachel B. Issaka;CynthiaW. Ko;Uri Ladabaum;Douglas J. Robertson - 通讯作者:
Douglas J. Robertson
The Path to Gastroenterology & Hepatology Leadership: Inadvertently Perpetuating the Glass Ceiling and Sticky Floor.
胃肠病学之路
- DOI:
- 发表时间:
2020 - 期刊:
- 影响因子:29.4
- 作者:
L. VanWagner;Rachel B. Issaka - 通讯作者:
Rachel B. Issaka
907 COST-EFFECTIVENESS OF A RIDESHARE PROGRAM TO PROMOTE FOLLOW-UP COLONOSCOPY COMPLETION
- DOI:
10.1016/s0016-5085(24)00992-2 - 发表时间:
2024-05-18 - 期刊:
- 影响因子:
- 作者:
Rachel B. Issaka;Laura Matrajt;Pedro Nascimento de Lima;Carolyn M. Rutter - 通讯作者:
Carolyn M. Rutter
Mo1014 LIMITED USE OF MEASURES OF STRUCTURAL RACISM AND DISCRIMINATION IN GASTROENTEROLOGY AND HEPATOLOGY STUDIES: A SCOPING REVIEW
- DOI:
10.1016/s0016-5085(23)02696-3 - 发表时间:
2023-05-01 - 期刊:
- 影响因子:
- 作者:
Joy Liu;Nicole Decuir;Leila Kia;Jonna Peterson;Corinne H. Miller;Rachel B. Issaka - 通讯作者:
Rachel B. Issaka
Rachel B. Issaka的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rachel B. Issaka', 18)}}的其他基金
Developing an intervention to improve follow-up of abnormal fecal immunochemical test results in a safety-net population using a mixed methods approach
使用混合方法制定干预措施,以改善安全网人群中异常粪便免疫化学检测结果的随访
- 批准号:
10601330 - 财政年份:2019
- 资助金额:
$ 28.88万 - 项目类别:
Developing an intervention to improve follow-up of abnormal fecal immunochemical test results in a safety-net population using a mixed methods approach
使用混合方法制定干预措施,以改善安全网人群中异常粪便免疫化学检测结果的随访
- 批准号:
10472516 - 财政年份:2019
- 资助金额:
$ 28.88万 - 项目类别:
Developing an intervention to improve follow-up of abnormal fecal immunochemical test results in a safety-net population using a mixed methods approach
使用混合方法制定干预措施,以改善安全网人群中异常粪便免疫化学检测结果的随访
- 批准号:
10684912 - 财政年份:2019
- 资助金额:
$ 28.88万 - 项目类别:
相似海外基金
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
- 批准号:
10057526 - 财政年份:2023
- 资助金额:
$ 28.88万 - 项目类别:
Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
- 批准号:
490105 - 财政年份:2023
- 资助金额:
$ 28.88万 - 项目类别:
Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
- 批准号:
2325465 - 财政年份:2023
- 资助金额:
$ 28.88万 - 项目类别:
Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
- 批准号:
10821172 - 财政年份:2023
- 资助金额:
$ 28.88万 - 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
- 批准号:
10766947 - 财政年份:2023
- 资助金额:
$ 28.88万 - 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
- 批准号:
10772887 - 财政年份:2023
- 资助金额:
$ 28.88万 - 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 28.88万 - 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
- 批准号:
10748465 - 财政年份:2023
- 资助金额:
$ 28.88万 - 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
- 批准号:
10591441 - 财政年份:2023
- 资助金额:
$ 28.88万 - 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
- 批准号:
491109 - 财政年份:2023
- 资助金额:
$ 28.88万 - 项目类别:
Fellowship Programs